TYBR Health Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $30M

  • Investors
  • 15

TYBR Health General Information

Description

Developer of a collagen-based resorbable hydrogel designed to protect healing tendons and ligaments and support recovery after surgery. The company offers a gel delivered through a proprietary applicator that is compatible with open and minimally invasive procedures, creating a protective barrier at the repair site, enabling clinicians to reduce complications that can impair tissue function.

Contact Information

Website
www.tybrhealth.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2450 Holcombe Boulevard
  • Suite X
  • Houston, TX 77021
  • United States
+1 (832)
Primary Industry
Medical Supplies
Other Industries
Therapeutic Devices
Vertical(s)
HealthTech
Corporate Office
  • 2450 Holcombe Boulevard
  • Suite X
  • Houston, TX 77021
  • United States
+1 (832)

TYBR Health Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TYBR Health Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC (Series A) 21-Jul-2026 $30M Completed Pre-Clinical Trials
9. Seed Round 26-Nov-2025 Completed Pre-Clinical Trials
8. Accelerator/Incubator 21-Apr-2025 Completed Pre-Clinical Trials
7. Accelerator/Incubator 29-May-2024 Completed Pre-Clinical Trials
6. Accelerator/Incubator 15-Jul-2022 Completed Pre-Clinical Trials
5. Accelerator/Incubator 01-Mar-2022 Completed Startup
4. Accelerator/Incubator 01-Jan-2022 Completed Startup
3. Grant 11-Aug-2021 Completed Startup
2. Grant 09-Jun-2021 $1K $1.06M Completed Startup
1. Seed Round 03-Mar-2021 $1.06M $1.06M Completed Startup
To view TYBR Health’s complete valuation and funding history, request access »

TYBR Health Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A-3
Series A-2
Series A-1
Seed Prime-2
Seed Prime-1 5,320,881 $0.000010 8% $1.46 $1.46 1x $1.46 14.29%
Seed 1,697,498 $0.000010 8% $0.63 $0.63 1x $0.63 4.56%
To view TYBR Health’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

TYBR Health Patents

  • 4

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 4

    Pending

  • Expiring in next 12 mo

TYBR Health Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026222241-A1 Systems, devices and methods to reduce post-operative tissue adhesion formation Pending 16-Apr-2025
US-20260157932-A1 Devices and methods for delivery of multi-component fluids Pending 17-Apr-2024
WO-2025221923-A1 Devices and methods for delivery of multi-component fluids Pending 17-Apr-2024
US-20230372615-A1 Systems and methods for delivery of multi-component fluids Pending 30-Nov-2020 A61M5/19

TYBR Health Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TYBR Health Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
Mutual Capital Partners Venture Capital Minority
Neovate Capital Partners Venture Capital Minority
Vensana Capital Venture Capital Minority
Asymmetry Ventures Venture Capital Minority
Johnson & Johnson Innovation - JLABS Accelerator/Incubator Minority
You’re viewing 5 of 15 investors. Get the full list »

Ready to get started?

Request a free trial

TYBR Health FAQs

  • When was TYBR Health founded?

    TYBR Health was founded in 2020.

  • Where is TYBR Health headquartered?

    TYBR Health is headquartered in Houston, TX.

  • What is the size of TYBR Health?

    TYBR Health has 4 total employees.

  • What industry is TYBR Health in?

    TYBR Health’s primary industry is Medical Supplies.

  • Is TYBR Health a private or public company?

    TYBR Health is a Private company.

  • What is the current valuation of TYBR Health?

    The current valuation of TYBR Health is .

  • What is TYBR Health’s current revenue?

    The current revenue for TYBR Health is .

  • How much funding has TYBR Health raised over time?

    TYBR Health has raised $38.7M.

  • Who are TYBR Health’s investors?

    Mutual Capital Partners, Neovate Capital Partners, Vensana Capital, Asymmetry Ventures, and Johnson & Johnson Innovation - JLABS are 5 of 15 investors who have invested in TYBR Health.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process